Mochi Health vs Fridays: Coverage, Cost, and GLP-1 Access

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

In this PlexusDx Education Hub review we focus on a single fault line between two GLP-1 programs: how each handles insurance and access. Browse all Peptides & GLP-1 education

This is an independent editorial review with no commercial ties. PlexusDx has no relationship with Mochi Health, Fridays, or their parent companies, and no affiliate links appear anywhere in this article.

Full head-to-head: PlexusDx vs Fridays →

The most meaningful gap between Mochi Health and Fridays is not the medicine — it is the access model. One leans toward insurance-assisted coverage; the other runs a cash-pay compounded program. For anyone deciding where GLP-1 care fits their budget, that distinction matters more than branding. Accurate as of April 2026.

Cash-pay compounding versus insurance-assisted access

These two programs sit on opposite ends of the payment spectrum. Mochi Health positions itself around telehealth with insurance support, while Fridays Health operates as a cash-pay telehealth service paired with a compounded-pharmacy pathway. That single difference ripples through eligibility, monthly cost, and what documentation each program asks you to provide.

How Mochi positions coverage

Mochi Health typically offers a virtual clinical evaluation, a provider-issued prescription, and either FDA-approved brand GLP-1 dispensing or compounded semaglutide and tirzepatide through a licensed pharmacy pathway, with insurance support as part of its pitch. Coverage outcomes always depend on your individual plan, so confirm specifics on Mochi Health's official website.

How Fridays positions its cash program

Fridays runs a straightforward cash-pay structure: no insurance billing, a flat published rate, and compounded medication dispensed through its pharmacy pathway. Program terms change, so check the live details at Fridays's official website before drawing any conclusions about eligibility or price.

Cost math when insurance is and isn't in the picture

With Fridays, the math is transparent because it is cash-pay: on its own pricing page (joinfridays.com/pricing, verified 2026-07-20) compounded semaglutide is $249/mo and compounded tirzepatide is $359/mo month-to-month, with no membership fee, free shipping, coaching, and dietitian support, and a paid-annually plan lowers the per-month figure to roughly $150 and $240. Fridays' rates shifted within a single day, so verify first. With an insurance-support model like Mochi, out-of-pocket cost depends entirely on your plan's formulary and prior-authorization rules. For comparison, PlexusDx month-to-month runs about $60–$70/mo below Fridays on both compounds, while Fridays' prepaid 3- and 6-month bundles undercut PlexusDx per month.

Clinical grounding for the GLP-1 class

No matter how a program is paid for, the science rests on the compound. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide were evaluated in STEP (semaglutide, weight management, NEJM 2021), SURMOUNT (tirzepatide, weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide, obstructive sleep apnea, NEJM 2024). Coverage status changes the price, never the pharmacology.

The inherited variable no coverage model captures

Whether a plan covers the drug or you pay cash, neither model reads the genetics underneath. Variants in FTO (a driver of fat-mass and obesity risk), GLP1R (the gene for the GLP-1 receptor targeted by every compound), MC4R (a satiety and energy-balance regulator), and TCF7L2 (tied to glucose homeostasis) outline the metabolic baseline a clinician prescribes against. These pathway-level markers do not predict compound response, but they describe your biology. PlexusDx adds that context: the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including FTO, MC4R, and TCF7L2, alongside its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Reading your baseline first turns guesswork into a grounded conversation with your provider.

No affiliation: PlexusDx is independent of Mochi Health and has no commercial relationship with any company covered here.

More from the PlexusDx Education Hub: What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist, GLP 1 Drugs.

Editorial disclaimer: this comparison is educational, not a recommendation to buy. PlexusDx is not affiliated with Mochi Health and sells semaglutide and tirzepatide through its own Weight Management Protocols. The Precision Peptide Genetic Test analyzes how genes influence peptide-related pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Look at a cash-pay path with genetics built in: see the Weight Management Protocols, or start with the Precision Peptide Genetic Test to map your GLP-1 pathway first.

Frequently Asked Questions

Does Mochi Health cover GLP-1 medication through insurance?

Mochi Health positions insurance support as part of its model, but actual coverage depends on your specific plan, its formulary, and prior-authorization requirements. Some plans cover GLP-1 medication for approved indications; many do not. Confirm the details with both Mochi and your insurer before assuming any out-of-pocket amount.

Is Fridays cheaper than Mochi if I have no coverage?

For an uninsured buyer the comparison is simpler because Fridays is cash-pay with published rates, while an insurance-support model can leave you paying full price if your plan declines. Neither is universally cheaper; run the numbers for your own coverage situation and verify current pricing on each brand's site.

Does the Precision Peptide Genetic Test affect my insurance coverage?

No. The test does not influence insurance decisions and does not predict response to any medication or program. It reads pathway-level variants in FTO and MC4R, and TCF7L2 that describe baseline GLP-1 biology — context that applies regardless of how your care is paid for.

How does the PlexusDx approach compare on access?

PlexusDx offers cash-pay semaglutide and tirzepatide protocols paired with the Precision Peptide Genetic Test. Rather than navigating coverage, it emphasizes transparent pricing plus pathway-level genetic context on FTO, MC4R — a layer neither Mochi's insurance model nor Fridays' cash program places beside the medication.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.